Log in

OTCMKTS:ESALY - Eisai Stock Price, Forecast & News

$75.45
+3.27 (+4.53 %)
(As of 12/6/2019 02:43 AM ET)
Today's Range
$65.56
Now: $75.45
$76.39
50-Day Range
$51.21
MA: $68.45
$75.74
52-Week Range
$48.52
Now: $75.45
$89.78
Volume58,200 shs
Average Volume10,579 shs
Market Capitalization$21.62 billion
P/E Ratio37.91
Dividend Yield1.72%
Beta0.38
Eisai Co, Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. It develops Fycompa, an antiepileptic drug in the neurology area that is approved as an adjunctive therapy for partial-onset seizures in Japan, the United States, Europe, and Asia. The company is also approved for use as monotherapy for the treatment of partial onset seizures in the United States; and as an adjunctive therapy for primary generalized tonic-clonic seizures in Japan, the United States, Europe, and Asia. Read More…

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ESALY
CUSIPN/A
Phone813-3817-3700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.79 billion
Cash Flow$2.88 per share
Book Value$20.48 per share

Profitability

Net Income$570.47 million

Miscellaneous

Employees10,456
Market Cap$21.62 billion
Next Earnings Date2/3/2020 (Estimated)
OptionableNot Optionable

Receive ESALY News and Ratings via Email

Sign-up to receive the latest news and ratings for ESALY and its competitors with MarketBeat's FREE daily newsletter.


Eisai (OTCMKTS:ESALY) Frequently Asked Questions

What is Eisai's stock symbol?

Eisai trades on the OTCMKTS under the ticker symbol "ESALY."

How were Eisai's earnings last quarter?

Eisai Co., Ltd (OTCMKTS:ESALY) announced its quarterly earnings data on Wednesday, October, 30th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.59 by $0.42. The company had revenue of $1.35 billion for the quarter. Eisai had a net margin of 9.10% and a return on equity of 9.07%. View Eisai's Earnings History.

When is Eisai's next earnings date?

Eisai is scheduled to release their next quarterly earnings announcement on Monday, February 3rd 2020. View Earnings Estimates for Eisai.

What is the consensus analysts' recommendation for Eisai?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eisai in the last year. There are currently 3 sell ratings, 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Eisai.

Has Eisai been receiving favorable news coverage?

News stories about ESALY stock have trended somewhat positive this week, InfoTrie reports. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Eisai earned a daily sentiment score of 2.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Eisai.

Who are some of Eisai's key competitors?

What other stocks do shareholders of Eisai own?

Who are Eisai's key executives?

Eisai's management team includes the folowing people:
  • Mr. Haruo Naito, CEO, Representative Corp. Officer & Director (Age 72)
  • Mr. Gary Hendler, Sr. VP & Pres of EMEA Region (Age 53)
  • Dr. Lynn D. Kramer, VP and Chief Clinical Officer & Chief Medical Officer - Neurology Bus. Group (Age 69)
  • Mr. Alexander Scott, VP, Chief Strategy Officer & Head of Strategy Dept. - Neurology Bus. Group
  • Ms. Shaji Procida, VP and Pres & COO of Eisai Inc. (Age 48)

How do I buy shares of Eisai?

Shares of ESALY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Eisai's stock price today?

One share of ESALY stock can currently be purchased for approximately $75.45.

How big of a company is Eisai?

Eisai has a market capitalization of $21.62 billion and generates $5.79 billion in revenue each year. The company earns $570.47 million in net income (profit) each year or $1.99 on an earnings per share basis. Eisai employs 10,456 workers across the globe.View Additional Information About Eisai.

What is Eisai's official website?

The official website for Eisai is http://www.eisai.co.jp/.

How can I contact Eisai?

Eisai's mailing address is 4-6-10 Koishikawa Bunkyo-ku, Tokyo M0, 112-8088. The company can be reached via phone at 813-3817-3700.


MarketBeat Community Rating for Eisai (OTCMKTS ESALY)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  205 (Vote Outperform)
Underperform Votes:  202 (Vote Underperform)
Total Votes:  407
MarketBeat's community ratings are surveys of what our community members think about Eisai and other stocks. Vote "Outperform" if you believe ESALY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ESALY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Featured Article: Balanced Fund

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel